Multiple Sclerosis :: Fty720 – fingolimod reduces multiple sclerosis symptoms

The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide.

Obesity :: Overweight in Early Childhood Increases Chances for Obesity at Age 12

Children who are overweight as toddlers or preschoolers are more likely to be overweight or obese in early adolescence, report researchers in a collaborative study by the NIH and several academic institutions. The researchers periodically collected height and weight measurements of a sample of children, beginning at age 2 and continuing until age 12. Their analysis, appearing in the September Pediatrics, provides some of the strongest evidence to date that overweight in early childhood increase the chances for overweight in later life.

Pregnancy :: Pregnancy risky after heart defect repair

New data suggests that women who have undergone a successful surgery to repair congenital heart defects can become pregnant, but they may have clinically significant complications. Until recently, pregnancy was discouraged in women who have undergone the so-called “Fontan operation” to correct complex birth defects of the heart. However, case reports and one clinical study suggest that women can become pregnant and deliver healthy infants.

Diabetes :: Exercise cuts diabetes risk in people with big waists

Exercise can help people with large waistlines reduce their risk of developing type 2 diabetes, Finnish researchers said. Type 2 diabetes, the more common form of the illness caused by an inability to make or properly use insulin, is linked to being overweight or obese.

Cholesterol :: Lipitor reduces stroke risk

In people who have experienced a stroke, but who have no known history of coronary heart disease, beginning regular treatment with the cholesterol-lowering drug atorvastatin soon after the stroke can reduce the risk of recurrent stroke by 16 percent, according to a five-year study led by an international team that includes a researcher at Duke University Medical Center.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack